Marker Therapeutics, Inc., based in Houston, TX, announced that Dr. Juan Vera is the CEO and the company is participating in the Wainwright conference.
4 reports, 2 independent
Updated 00:00
Still developing
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Marker Therapeutics, Inc., based in Houston, TX, announced that Dr. Juan Vera is the CEO and the company is participating in the Wainwright conference.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Marker Therapeutics received an exclusive license from Baylor and secured FDA grant funding.1 source
Marker Therapeutics, Inc. (Houston) announced CEO Juan Vera and participation in the Wainwright conference.1 source
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- manilatimes.net
- GlobeNewswireMarker Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRK
- GlobeNewswireMarker Therapeutics Provides Update on Phase 1 APOLLO Study Highlighting Encouraging Overall Response Rates in Relapsed Lymphoma Ongoing Phase 1 APOLLO study investigating MT-601 in patients with rel
- GlobeNewswireMarker Therapeutics to Participate in a Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a cli